150 participants
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-11-25
- Start Date:
- 2023-10-10
- Completion:
- 2027-05-31
Conditions
- NSCLC
Interventions
- DRUG
No Results Yet